Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Other Accumulated Expenses (2016 - 2025)

Corcept Therapeutics (CORT) has disclosed Other Accumulated Expenses for 12 consecutive years, with $34.0 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses changed 0.25% to $34.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.0 million through Dec 2025, changed 0.25% year-over-year, with the annual reading at $34.0 million for FY2025, 0.25% changed from the prior year.
  • Other Accumulated Expenses hit $34.0 million in Q4 2025 for Corcept Therapeutics, up from $28.3 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $34.0 million in Q4 2025 to a low of $12.4 million in Q4 2021.
  • Historically, Other Accumulated Expenses has averaged $23.1 million across 5 years, with a median of $21.7 million in 2023.
  • Biggest five-year swings in Other Accumulated Expenses: soared 58.78% in 2024 and later increased 0.25% in 2025.
  • Year by year, Other Accumulated Expenses stood at $12.4 million in 2021, then increased by 17.13% to $14.6 million in 2022, then soared by 46.37% to $21.3 million in 2023, then skyrocketed by 58.78% to $33.9 million in 2024, then increased by 0.25% to $34.0 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for CORT at $34.0 million in Q4 2025, $28.3 million in Q3 2025, and $29.0 million in Q2 2025.